| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Viridian Therapeutics, Inc.\de (VRDN) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 14 sells. VRDN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.91M | $65.33M | - | |
| Dir | 21.0K | $350.5K | - | |
| Dir | 21.0K | $350.5K | - | |
| Dir | 21.0K | $350.5K | - | |
| Dir | 21.0K | $350.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 9, 2023 | Meisner Lara74 | General Counsel And Secretary | Sell | 29,971 | $29.07 | $871,256.97 | -100% | -14.2% | -34.7% | |
| Feb 2, 2023 | Violin Jonathan47 | Chief Executive Officer | Sell | 50,000 | $36.80 | $1,840,000.00 | -10.4% | -25.1% | -49.2% | |
| Jan 23, 2023 | Meisner Lara74 | General Counsel And Secretary | Sale+OE | 6,843 | $35.66 | $244,021.38 | -100% | -18.4% | -46.9% | |
| Jan 17, 2023 | Katz Barrett73 | Chief Medical Officer | Sale+OE | 29,000 | $37.18 | $1,078,260.60 | -100% | -28.7% | -40.6% | |
| Jan 10, 2023 | Katz Barrett73 | Chief Medical Officer | Sale+OE | 60,000 | $34.82 | $2,089,472.02 | -100% | -30.5% | -32.9% | |
| Dec 21, 2022 | Meisner Lara74 | General Counsel And Secretary | Sale+OE | 16,926 | $29.15 | $493,397.94 | -100% | -9.5% | -27.7% | |
| Dec 16, 2022 | Meisner Lara74 | General Counsel And Secretary | Sale+OE | 1,597 | $28.37 | $45,310.68 | -100% | +2.6% | -31.1% | |
| Dec 14, 2022 | Meisner Lara74 | General Counsel And Secretary | Sale+OE | 16,256 | $28.12 | $457,076.72 | -100% | +2.2% | -30.7% | |
| Nov 15, 2022 | Meisner Lara74 | General Counsel And Secretary | Sale+OE | 8,125 | $22.05 | $179,156.25 | -100% | +44.2% | -30.1% | |
| Aug 17, 2022 | Fairmount Funds Management LLC73 | Director, 10% Owner, See Remarks | Buy | 425,531 | $23.50 | $9,999,978.50 | +45.4% | +0.3% | -16.4% |